Helus Pharma: Canaccord Genuity raises target price to $58 from $42
HELP•Canaccord Genuity raised its target price for Helus Pharma to $58 from $42.
Related News

US oil to revisit November 10 low of $83.88
USO•

Sea CCO and GC Wang Yanjun reports sale of $119,299.30 in common shares
SE•

Light & Wonder grants Jamie Odell 16,413 restricted stock units for consulting services
LNW•

Steel Dynamics Inc: Jefferies cuts target price to $280 from $310
STLD•

RBC cuts CG Oncology to sector perform from outperform; raises target price to $97 from $80
CGON•